Florida · J2250

Injection, Midazolam Hydrochloride, Per 1 Mg in Florida

Florida Medicare Avg
$0.13
5% above national avg
National Medicare Avg
$0.12
All states combined
Billed Charge (FL)
$9.13
What providers submit
Est. Commercial (FL)
$0.37
National avg: $0.34
Est. Cash / Self-Pay (FL)
$2.63
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

18.4K
Services in FL
165
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Florida

Provider Medicare Services
Valente, Louis M.D. $0.12 1.8K
Ball, Robert D.O. $0.12 1.7K
Hanna, Ashraf $0.12 1.4K
Voepel, Li Jin MD $0.12 753
Caudill, Jeffrey M.D. $0.12 648
Lenchig, Sergio M.D. $0.17 614
Shores, Aaron MD $0.12 595
Udeshi, Ashish M.D. $0.12 496
Sharma, Tushar M.D. $0.12 487
Lew, David M.D. $0.12 396
Sahai, Ashish MD $0.12 390
Beirne, Daniel M.D. $0.12 349

Florida Pricing in Context

In Florida, CPT code J2250 (Injection, Midazolam Hydrochloride, Per 1 Mg) carries an average Medicare payment of $0.13 — 5% above the national benchmark of $0.12. 165 providers across the state submitted claims for this procedure in 2023, performing 18.4K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Florida is $9.13, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Florida lands near $0.37, with self-pay cash prices typically around $2.63. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Midazolam Hydrochloride, Per 1 Mg cost in Florida?

The average Medicare payment for Injection, Midazolam Hydrochloride, Per 1 Mg in Florida is $0.13, which is 5% above the national average of $0.12. Providers in FL typically bill $9.13 for this procedure.

What does Injection, Midazolam Hydrochloride, Per 1 Mg cost with insurance in Florida?

With commercial insurance in Florida, Injection, Midazolam Hydrochloride, Per 1 Mg costs an estimated $0.37. Without insurance, the estimated cash price is $2.63. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Midazolam Hydrochloride, Per 1 Mg in Florida?

165 providers in Florida billed Medicare for Injection, Midazolam Hydrochloride, Per 1 Mg in 2023, performing 18.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Midazolam Hydrochloride, Per 1 Mg cheaper in Florida than the national average?

No — Injection, Midazolam Hydrochloride, Per 1 Mg costs 5% above the national average in Florida. The state average Medicare payment is $0.13 compared to $0.12 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial